Elizabeth S Klings1, Diego F Wyszynski, Vikki G Nolan, Martin H Steinberg. 1. Pulmonary Center, Department of Medicine, Boston Comprehensive Sickle Cell Center, Boston University School of Medicine and School of Public Health, Boston, MA 02118, USA. eklings@lung.bumc.bu.edu
Abstract
RATIONALE: Pulmonary complications of sickle cell anemia (Hb-SS) commonly cause morbidity, yet few large studies of pulmonary function tests (PFTs) in this population have been reported. OBJECTIVES: PFTs (spirometry, lung volumes, and diffusion capacity for carbon monoxide [DLCO]) from 310 adults with Hb-SS were analyzed to determine the pattern of pulmonary dysfunction and their association with other systemic complications of sickle cell disease. METHODS: Raw PFT data were compared with predicted values. Each subject was subclassified into one of five groups: obstructive physiology, restrictive physiology, mixed obstructive/restrictive physiology, isolated low DLCO, or normal. The association between laboratory data of patients with decreased DLCO or restrictive physiology and those of normal subjects was assessed by multivariate linear regression. MEASUREMENTS AND MAIN RESULTS: Normal PFTs were present in only 31 of 310 (10%) patients. Overall, adults with Hb-SS were characterized by decreased total lung capacities (70.2 +/- 14.7% predicted) and DLCO (64.5 +/- 19.9%). The most common PFT patterns were restrictive physiology (74%) and isolated low DLCO (13%). Decreased DLCO was associated with thrombocytosis (p = 0.05), with hepatic dysfunction (elevated alanine aminotransferase; p = 0.07), and a trend toward renal dysfunction (elevated blood urea nitrogen and creatinine; p = 0.05 and 0.07, respectively). CONCLUSIONS: Pulmonary function is abnormal in 90% of adult patients with Hb-SS. Common abnormalities include restrictive physiology and decreased DLCO. Decreased DLCO may indicate more severe sickle vasculopathy characterized by impaired hepatic and renal function.
RATIONALE: Pulmonary complications of sickle cell anemia (Hb-SS) commonly cause morbidity, yet few large studies of pulmonary function tests (PFTs) in this population have been reported. OBJECTIVES: PFTs (spirometry, lung volumes, and diffusion capacity for carbon monoxide [DLCO]) from 310 adults with Hb-SS were analyzed to determine the pattern of pulmonary dysfunction and their association with other systemic complications of sickle cell disease. METHODS: Raw PFT data were compared with predicted values. Each subject was subclassified into one of five groups: obstructive physiology, restrictive physiology, mixed obstructive/restrictive physiology, isolated low DLCO, or normal. The association between laboratory data of patients with decreased DLCO or restrictive physiology and those of normal subjects was assessed by multivariate linear regression. MEASUREMENTS AND MAIN RESULTS: Normal PFTs were present in only 31 of 310 (10%) patients. Overall, adults with Hb-SS were characterized by decreased total lung capacities (70.2 +/- 14.7% predicted) and DLCO (64.5 +/- 19.9%). The most common PFT patterns were restrictive physiology (74%) and isolated low DLCO (13%). Decreased DLCO was associated with thrombocytosis (p = 0.05), with hepatic dysfunction (elevated alanine aminotransferase; p = 0.07), and a trend toward renal dysfunction (elevated blood ureanitrogen and creatinine; p = 0.05 and 0.07, respectively). CONCLUSIONS: Pulmonary function is abnormal in 90% of adult patients with Hb-SS. Common abnormalities include restrictive physiology and decreased DLCO. Decreased DLCO may indicate more severe sickle vasculopathy characterized by impaired hepatic and renal function.
Authors: G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis Journal: Ann Intern Med Date: 1991-09-01 Impact factor: 25.391
Authors: M Gaston; J Smith; D Gallagher; Z Flournoy-Gill; S West; R Bellevue; M Farber; R Grover; M Koshy; A K Ritchey Journal: Control Clin Trials Date: 1987-12
Authors: Claudia R Morris; Hae-Young Kim; Elizabeth S Klings; John Wood; John B Porter; Felicia Trachtenberg; Nancy Sweeters; Nancy F Olivieri; Janet L Kwiatkowski; Lisa Virzi; Kathryn Hassell; Ali Taher; Ellis J Neufeld; Alexis A Thompson; Sandra Larkin; Jung H Suh; Elliott P Vichinsky; Frans A Kuypers Journal: Br J Haematol Date: 2015-04-24 Impact factor: 6.998
Authors: Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Ian R Hambleton; Gavin Cho Journal: Cochrane Database Syst Rev Date: 2016-05-20
Authors: Borna Mehrad; Marie D Burdick; Nancy J Wandersee; Kaushik S Shahir; Liyun Zhang; Pippa M Simpson; Robert M Strieter; Joshua J Field Journal: Blood Adv Date: 2017-11-06
Authors: Joshua J Field; Jeffrey Glassberg; Annette Gilmore; Joanna Howard; Sameer Patankar; Yan Yan; Sally C Davies; Michael R Debaun; Robert C Strunk Journal: Am J Hematol Date: 2008-07 Impact factor: 10.047
Authors: Adedoyin O Dosunmu; Rachael A Akinola; Josephine A Onakoya; Taiwo M Balogunt; Olufunke O Adeyeye; Akinsegun A Akinbami; Olanrewaju M Arogundade; Ayodeji T Brodie-Mends Journal: Caspian J Intern Med Date: 2013